We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioventix PLC | AQSE:BVXP.GB | Aquis Stock Exchange | Ordinary Share | GB00B4QVDF07 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,200.00 | 3,100.00 | 3,300.00 | 3,200.00 | 3,200.00 | 3,200.00 | 0.00 | 06:55:26 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Dec 2022 to Dec 2024
TIDMBVXP
RNS Number : 0811W
BioVentix PLC
07 December 2023
Bioventix plc
("Bioventix" or the "Company")
Result of AGM
Bioventix plc (AIM: BVXP) a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were duly passed.
For further information please contact:
Bioventix plc Tel: 01252 728 001 Peter Harrison Chief Executive Officer Bruce Hiscock Chief Financial Officer finnCap Ltd Tel: 020 7220 0500 Geoff Nash / Simon Corporate Finance Hicks ECM Nigel Birks / Harriet Ward
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGBUBDDUDGDGXR
(END) Dow Jones Newswires
December 07, 2023 10:26 ET (15:26 GMT)
1 Year Bioventix Chart |
1 Month Bioventix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
